These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36646176)

  • 1. Effects of Gender-affirming Hormone Therapy on Orgasm Function of Transgender Men and Women: A Long Term Follow Up.
    Zaliznyak M; Lauzon M; Stelmar J; Yuan N; Smith SM; Garcia MM
    Urology; 2023 Apr; 174():86-91. PubMed ID: 36646176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Proposed Inventory to Assess Changes in Orgasm Function of Transgender Patients Following Gender Affirming Treatments: Pilot Study.
    Zaliznyak M; Lauzon M; Stelmar J; Yuan N; Smith SM; Garcia MM
    Sex Med; 2022 Jun; 10(3):100510. PubMed ID: 35472753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing Dermatological Conditions in the Transgender Population: A Cross-Sectional Study.
    Rutnin S; Suchonwanit P; Kositkuljorn C; Pomsoong C; Korpaisarn S; Arunakul J; Rattananukrom T
    Transgend Health; 2023 Feb; 8(1):89-99. PubMed ID: 36824384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual Desire Changes in Transgender Individuals Upon Initiation of Hormone Treatment: Results From the Longitudinal European Network for the Investigation of Gender Incongruence.
    Defreyne J; Elaut E; Kreukels B; Fisher AD; Castellini G; Staphorsius A; Den Heijer M; Heylens G; T'Sjoen G
    J Sex Med; 2020 Apr; 17(4):812-825. PubMed ID: 32008926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Gender-Affirming Hormone Therapy on Serum Creatinine in Transgender Individuals.
    Maheshwari A; Dines V; Saul D; Nippoldt T; Kattah A; Davidge-Pitts C
    Endocr Pract; 2022 Jan; 28(1):52-57. PubMed ID: 34474185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
    Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
    J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
    Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of Emtricitabine/Tenofovir Disoproxil Fumarate Among Transgender Adolescents and Young Adults Without HIV Receiving Gender Affirming Hormones.
    Yager J; Brooks KM; Brothers J; Mulligan K; Landovitz R; Reirden D; Glenny C; Malhotra M; Anderson PL; Hosek S
    AIDS Res Hum Retroviruses; 2022 Nov; 38(11):840-846. PubMed ID: 35943868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new angle on mental rotation ability in transgender men: Modulation by ovarian milieu.
    Peragine DE; Gervais NJ; Simeon-Spezzaferro C; Einstein G
    Psychoneuroendocrinology; 2022 Jul; 141():105751. PubMed ID: 35398751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
    Foster Skewis L; Bretherton I; Leemaqz SY; Zajac JD; Cheung AS
    Front Endocrinol (Lausanne); 2021; 12():717766. PubMed ID: 34394009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
    Zaliznyak M; Jung EE; Bresee C; Garcia MM
    J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender-Affirming Hormone Pharmacokinetics Among Adolescent and Young Adult Transgender Persons Receiving Daily Emtricitabine/Tenofovir Disoproxil Fumarate.
    Yager J; Brooks KM; Brothers J; Mulligan K; Landovitz RJ; Reirden D; Malhotra M; Glenny C; Harding P; Powell T; Anderson PL; Hosek S
    AIDS Res Hum Retroviruses; 2022 Dec; 38(12):939-943. PubMed ID: 35815468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sperm quality in transgender women before or after gender affirming hormone therapy-A prospective cohort study.
    Rodriguez-Wallberg KA; Häljestig J; Arver S; Johansson ALV; Lundberg FE
    Andrology; 2021 Nov; 9(6):1773-1780. PubMed ID: 33683832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender minority stress in transgender people: a major role for social network.
    Collet S; Kiyar M; Martens K; Vangeneugden J; Simpson VG; Guillamon A; Mueller SC; T'Sjoen G
    J Sex Med; 2023 May; 20(6):905-917. PubMed ID: 37102304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-affirming hormone therapy induces specific DNA methylation changes in blood.
    Shepherd R; Bretherton I; Pang K; Mansell T; Czajko A; Kim B; Vlahos A; Zajac JD; Saffery R; Cheung A; Novakovic B
    Clin Epigenetics; 2022 Feb; 14(1):24. PubMed ID: 35177097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.
    Glintborg D; Rubin KH; Kristensen SB; Lidegaard Ø; T'Sjoen G; Hilden M; Andersen MS
    Andrology; 2022 Jul; 10(5):885-893. PubMed ID: 35366390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI).
    Cocchetti C; Castellini G; Iacuaniello D; Romani A; Maggi M; Vignozzi L; Schreiner T; den Heijer M; T'Sjoen G; Fisher AD
    J Sex Med; 2021 Apr; 18(4):821-829. PubMed ID: 33745831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of gender affirming hormone therapy on body mass index in transgender individuals: A longitudinal cohort study.
    Suppakitjanusant P; Ji Y; Stevenson MO; Chantrapanichkul P; Sineath RC; Goodman M; Alvarez JA; Tangpricha V
    J Clin Transl Endocrinol; 2020 Sep; 21():100230. PubMed ID: 32685379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How Early in Life do Transgender Adults Begin to Experience Gender Dysphoria? Why This Matters for Patients, Providers, and for Our Healthcare System.
    Zaliznyak M; Yuan N; Bresee C; Freedman A; Garcia MM
    Sex Med; 2021 Dec; 9(6):100448. PubMed ID: 34731778
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.